Viewing Study NCT03961659


Ignite Creation Date: 2025-12-24 @ 2:56 PM
Ignite Modification Date: 2026-02-04 @ 11:36 AM
Study NCT ID: NCT03961659
Status: UNKNOWN
Last Update Posted: 2019-05-23
First Post: 2019-05-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
None Obesity View
None Cognitive Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Functional MRI View
None Olfactory function View
None Liraglutid View
None Dapagliflozin View
None Acarbose View